相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long term pharmacotherapy for obesity and overweight: updated meta-analysis
Diana Rucker et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA
Rosa Maria Vitale et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Drug treatment of the overweight patient
George A. Bray et al.
GASTROENTEROLOGY (2007)
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Raj S. Padwal et al.
LANCET (2007)
Current and novel approaches to the drug therapy of obesity
Jean-Philippe Chaput et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Investigational therapies in the treatment of obesity
Marcio C. Mancini et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Safety of drug therapies used for weight loss and treatment of obesity
LL Ioannides-Demos et al.
DRUG SAFETY (2006)
Zonisamide: Review of its use in epilepsy therapy
G Zareba
DRUGS OF TODAY (2005)
Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies
G De Simone et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders
R Canitano
BRAIN & DEVELOPMENT (2005)
Current and investigational antiobesity agents and obesity therapeutic treatment targets
HE Bays
OBESITY RESEARCH (2004)
Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production
S Obici et al.
NATURE MEDICINE (2003)
Zonisamide for weight loss in obese adults - A randomized controlled trial
KM Gadde et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Carbonic anhydrase inhibitors:: SAR and x-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with Isozymes I, II and IV
A Casini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)
Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes - A 1-year randomized controlled trial
DE Kelley et al.
DIABETES CARE (2002)
Applications of carbonic anhydrase inhibitors and activators in therapy
CT Supuran et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2002)
Carbonic anhydrase: New insights for an ancient enzyme
BC Tripp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Orlistat inhibits dietary cholesterol absorption
B Mittendorfer et al.
OBESITY RESEARCH (2001)
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
M Bialer et al.
EPILEPSY RESEARCH (2001)
Effect of sibutramine on weight maintenance after weight loss:: a randomised trial
WPT James et al.
LANCET (2000)
Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats
F Picard et al.
OBESITY RESEARCH (2000)
A comparison of topiramate and acetazolamide on seizure duration and paired-pulse inhibition in the dentate gyrus of the rat
JL Stringer
EPILEPSY RESEARCH (2000)
Newer anticonvulsants - Comparative review of drug interactions and adverse effects
A Sabers et al.
DRUGS (2000)
Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
SB Heymsfield et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Carbonic anhydrase inhibitors and their therapeutic potential
CT Supuran et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2000)
Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity
S Rossner et al.
OBESITY RESEARCH (2000)
The value of partial sleep deprivation as a routine measure in pediatric electroencephalography
S Liamsuwan et al.
JOURNAL OF CHILD NEUROLOGY (2000)
The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity Study
F Lindgarde
JOURNAL OF INTERNAL MEDICINE (2000)
分享论文
